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The left atrium (LA) is an important load-independent barometer of left ventricular filling 
pressure and diastolic dysfunction. In heart failure with preserved ejection fraction (HFpEF) 
measuring left atrial volume has come into vogue not least because LA dilatation forms part of 
the diagnostic criteria1 but also as increased size is associated with worse outcomes2. 
Moreover, atrial reverse remodelling has been used as a surrogate marker of therapeutic 
success in clinical trials.  
Volumetric short axis Simpson’s methods using cardiovascular magnetic resonance (CMR)3,4 is 
widely considered gold-standard technique for calculating left atrial volume. Echocardiography 
is an alternative modality and, though more widely available and versatile than CMR, it has 
poorer spatial resolution and generally underestimates the true volume compared to CMR3,5. 
Multiple validation studies comparing the two modalities have focused on healthy volunteers 
alone. We sought to investigate whether LA volume calculated by 2D transthoracic 
echocardiography (biplane area-length [BAL] method) and CMR (BAL and gold standard 
volumetric Simpson’s methods [CMR GS]) were comparable in a cohort of patients with HFpEF. 
We analysed 72 paired studies - echocardiograms (using a Philips iE33 machine with a S5-1 
transducer) and CMR (1.5T Siemens Avanto Healthcare, Erlangen, Germany and analysed on 
CMRtools, Cardiovascular Imaging Solutions, London, UK) from 25 patients (age 74±6 years, 15 
male) with HFpEF who participated in the Renal Denervation in HFpEF (RDT-PEF) study at our 
institution (Clinicaltrials.gov identifier: NCT01840059), three patients only had two CMR 
studies. The study protocol conformed to 1975 Helsinki guidelines, had been given regional 
ethical approval and all patients provided written informed consent.  
CMR and echocardiography studies were undertaken on the same day on three different 
occasions more than 90 days apart. For the CMR GS method, steady-state free precession 
(SSFP) cine imaging with contiguous stack of short-axis images across the LA was taken to 
calculate LA volume using the Simpson’s method as previously described by our group6. For the 
BAL method, both for echo and CMR standard 2 chamber and 4 chamber views were also 
obtained to calculate LA volume as previously described6.  
In total 43 studies were performed in atrial fibrillation (AF), and 29 in sinus rhythm (SR). The 
absolute LA volumes using the three methods were analysed by two blinded experienced level 
3 accredited observers (HP/ VV). LA volumes calculated from echocardiography using the BAL 
method were significantly lower than the CMR GS in the overall cohort (48.8±18.9mL/m2 vs 
68.6± 29.3mL/m2, p <0.0001) likely due to lower spatial resolution for detecting myocardial-
chamber borders7 and foreshortening8 (Table 1A).  
This difference was driven mainly by the presence of AF. Echo BAL vs CMR GS mean LA volume 
in SR was similar (39.5mL/m2 vs 41.6mL/m2, p=0.60) but different in AF (54.6mL/m2 vs 
72.6mL/m2, p<0.0001). However, comparison of the volumes derived from echocardiography 
BAL with the CMR GS method suggested good agreement when the LA volume was normal but 
a trend to systematic underestimation by echocardiography in patients with pathological LA 
enlargement (Figure 1A). This was more pronounced in patients with an LA volume >60mL/m2 
and the effect was compounded by presence of AF (Figure 1C and 1D). This phenomenon has 
been reported for dilated cardiomyopathy patients in sinus rhythm previously9 but this is the 
first study to report this phenomenon in patients with HFpEF and AF.  
There was no difference between the CMR GS and CMR BAL values (68.6±29.3mL/m2 vs 
64.7mL±29.4mL/m2, p=0.43)(Figure 1B).   
When compared to the CMR GS , echocardiography BAL incorrectly classified 4/14 (29%) 
patients as having normal LA volume when it was dilated on the CMR GS, and 16/58 as dilated 
(28%) when it was normal on the CMR GS (Table 1B) if upper limit of normal was taken as 
34mL/m2 for echocardiography and 53mL/m2 for CMR4,10. Likewise, when compared to the 
CMR GS the CMR BAL method incorrectly classified 3/23 (16%) as normal size and 6/43(14%) as 
dilated (table 1B).  
The main limitation of our study is that we only used 2D echocardiography. 3D 
echocardiography may show better agreement with the CMR GS but this was not investigated. 
Also, our number of subjects (n=25) was relatively small however with 72 studies this 
represents the largest HFpEF population studied to date with CMR.  
In conclusion, this is the first study to investigate patients with HFpEF with both CMR and 2D 
echocardiography for LA volume calculation. We have shown that CMR BAL method for 
estimating LA volume in both SR and AF correlated and agreed well with the gold standard 
volumetric short axis Simpson’s method. This suggests that in patients with HFpEF BAL volume 
calculation of LA with CMR BAL is reliable and can be considered to shorten scan duration. 2D 
echocardiographic data in patients with LA volume >60 mL/m2 appeared less accurate and 
measurements should be interpreted with caution, both in patients in SR and especially in AF.  
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Legend for Table 1 
Table 1. Panel A showing the absolute indexed LA volume values obtained with 
echocardiography BAL method, the CMR BAL method and the CMR GG. Echocardiography 
underestimated the true volume compared to the CMR GG, especially in pathological dilation 
and AF. There was no significant difference between the CMR BAL and CMRGG. Panel B 
demonstrating that atrial volumes calculated by echocardiography can classify patients 
incorrectly in 15/72 (21%) of the cases, whereas for CMR BAL method this is 9/72 (13%).  
 
BAL= Biplane Area Length method 
GG= Volumetric Simpson gold standard  




Legend for Figure 1 
Figure 1. Panel A showing a Bland-Altman plot of the echocardiographic BAL LA volume  
compared to the CMR GS showing that at normal volumes echocardiography performs well. 
However at higher LA volumes (~>60mL/m2) echocardiography systematically underestimates 
compared to the gold standard. Panel B showing a Bland-Altman plot of the CMR BAL compared 
to the CMR gold standard indicating good agreement independently of LA volume. Panel C 
showing echocardiographic BAL LA volume compared to the CMR GS in patients with SR 
suggesting that underestimation is present at pathological volumes even in SR, however panel 
1D shows that this is more pronounced in AF.  
BAL= Biplane Area Length method 
GG= Volumetric Simpson gold standard  
LA= Left atrium 
AF= Atrial Fibrillation 
SR= Sinus rhythm 
 
 
 
 
